Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines

Journal of Steroid Biochemistry and Molecular Biology

Volumn 55, Issue 3-4, 1995, Pages 423-437

  Schoonen, W G E J ^a   Joosten, J W H ^a   Kloosterboer, H J ^a  

^a NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA [4 (DIMETHYLAMINO)PHENYL] 4',5' DIHYDRO 6BETA METHYLSPIRO[ESTRA 4,9 DIENE 17BETA,2'(3'H) FURAN] 3 ONE; 16ALPHA ETHYL 21 HYDROXY 19 NORPREGN 4 ENE 3,20 DIONE; 17ALPHA HYDROXY 11 METHYLENE 19 NORPREGNA 4,15 DIEN 20 YN 3 ONE; 4 HYDROXYTAMOXIFEN; ANTIESTROGEN; ANTIGESTAGEN; ESTRADIOL; ESTROGEN RECEPTOR; ETONOGESTREL; GESTAGEN; GESTODENE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; NANDROLONE DERIVATIVE; NORETHISTERONE; PROGESTERONE; PROMEGESTONE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BREAST CANCER; CELL CULTURE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN CELL;

ADENOCARCINOMA; BREAST NEOPLASMS; CELL DIVISION; DESOGESTREL; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; LEVONORGESTREL; MEDROXYPROGESTERONE 17-ACETATE; MODELS, STATISTICAL; NANDROLONE; NORETHINDRONE; NORPREGNENES; PREGNANES; PREGNENEDIONES; PROGESTERONE; PROMEGESTONE; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0029417037     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(95)00215-4     Document Type: Article

References (30)

1. Steroids and steroid receptors in growth control of cultured breast cancer cells
2. Role of sex steroid hormones in normal mammary gland function
3. Progestagens and mammary gland development: differentiation versus carcinogenesis
4. Breast epithelial responses and steroid receptors during oral contraceptive use
5. Progestins and breast cancer: an epidemiologic review
6. Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells
7. Difference between R5020 and the antiprogestagen RU486 in antiproliferative effects on human breast cancer cells
8. Progestin effects on growth in the human breast cancer cell line T-47-D; possible therapeutic implications
9. Effects of progestins, estrogens, and antihormones on growth and lactate dehydrogenase in the human breast cancer cell line T-47-D
10. Growth stimulation and differential regulation of transforming growth factor-β1 (TGFβ1), TGFβ2, and TGFβ3 messenger RNA levels by norethisterone in MCF-7 breast tumor cells
11. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens
12. Multiple actions of synthetic progestins on the growth of ZR-75-1 human breast cancer cells: anin vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids
13. Influence of culture conditions on the estrogenic cell growth stimulation of human breast cancer cells
14. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture
15. Therapeutic potential of pure antioestrogens in the treatment of breast cancer
16. Non-steroidal antioestrogens; receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells
17. Effects of progestins on the proliferation of estrogen-dependent human breast tumor cells under growth factor-defined conditions
18. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation
19. co human breast cancer cells by progestins: implications for endocrine therapies
20. Effects of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells
21. Progestin regulation of cellular proliferation
22. A novel binding site for a synthetic progestagen in breast cancer
23. The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta
24. A rapid non-radioactive fluorescence assay for the measurement of both cell number and proliferation
25. Comparison of four DNA staining fluorescence dyes for measuring cell proliferation of lymphokine-activated killer (LAK) cells
26. Existence of multiple peaks in plasma ethinyl estradiol and norethisterone after oral administration of a contraceptive pill
27. GES binding in malignant human breast epithelial cell lines: exclusion of a specific binding protein by three radiolabelled ligand binding methods
28. Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells
29. Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor
30. Androgens induce divergent proliferative responses in human breast cancer cell lines